Human exposure of bisphenol A and its analogues: understandings from human urinary excretion data and wastewater-based epidemiology.

This work evaluated human exposure to bisphenol A (BPA) and its analogues based on human urinary excretion data and wastewater-based epidemiology (WBE). The results showed that the world's average human daily intake ranked from high to low is in order of bisphenol A (BPA), bisphenol F (BPF), bisphenol S (BPS), bisphenol P (BPP), bisphenol AP (BPAP), bisphenol B (BPB), bisphenol Z (BPZ), and bisphenol AF (BPAF), and their corresponding human daily intakes are 2.53, 0.68, 0.60, 0.41, 0.36, 0.29, 0.24, and 0.06 µg/p/day, respectively. BPA is clearly the dominant bisphenol for human exposure. However, the results also showed that humans have been widely exposed to BPA analogues as well. Many BPA analogues showed similar estrogenic activities to those of BPA; therefore, the adverse effects of BPA and its analogues on humans should be comprehensively evaluated. The nominal exposure levels obtained based on wastewater-based epidemiology ranked high to low are in order of BPA (513.73 µg/p/day), BPF (10.20 µg/p/day), BPS (5.21 µg/p/day), BPP (1.15 µg/p/day), BPZ (0.66 µg/p/day), BPB (0.61 µg/p/day), BPAF (0.58 µg/p/day), and BPAP (0.35 µg/p/day). The world's human average daily intakes of BPA and its analogues are only 0.5-47.9% of the intakes of their corresponding human nominal exposures. This study suggests that other sources rather human excretions are important origins in municipal wastewater, which indicates that the WBE method based on parent compounds is inappropriate for evaluations of human daily intakes of BPA and its analogues, neither for other industrial compounds that have multiple important sources. Three main important sources of BPA and its analogues in municipal wastewater are likely effluents of industrial wastewater, discharges of hospital wastewater, and landfill leachates. To decrease discharges of BPA and its analogues to the natural environment, any mixing of industrial and hospital wastewater as well as landfill leachates in municipal wastewater is not favorable.

Insights into removal mechanisms of bisphenol A and its analogues in municipal wastewater treatment plants.

The occurrence and removal mechanisms of bisphenol A (BPA) and its analogues in municipal WWTPs were critically reviewed in this article. BPA appeared to be the dominant bisphenol, and the removal efficiency of bisphenols was in the order of bisphenol AP>bisphenol P>bisphenol F>bisphenol Z>bisphenol C>bisphenol S>bisphenol B>BPA>bisphenol E>bisphenol AF. It was also found that BPA removal showed linear relationships to those of its analogues, which have been proven by BPA vs BPS or BPF. BPA removal performances in different treatment processes ranked from low to high are primary treatment, lagoon process, biological aerated filter, and activated sludge. Lab-scale studies showed that >50% BPA can be removed by sewage sludge estimated with the BPA solid water distribution coefficients, which showed that sludge adsorption played an important role on BPA removal. The theoretically predicted removal of BPA in municipal WWTP showed that it is readily biodegradable, which deviate from its on-site investigations. Existence of BPA conjugates in raw municipal wastewater as well as newly produced BPA degraded or migrated from microplastic materials are possible two main reasons.

Bisphenol A concentrations in human urine, human intakes across six continents, and annual trends of average intakes in adult and child populations worldwide: A thorough literature review.

Bisphenol A (BPA) is an important industrial raw material that is widely applied in daily products. BPA is also an endocrine-disrupting chemical that may adversely affect humans. This review thoroughly collected data on BPA concentration in human urine and determined main influencing factors. The average BPA intake of humans across six continents or the average value worldwide was calculated based on a simple model. Results showed that the average BPA intake was ranked from high to low as follows: Oceania, Asia, Europe, and North America in the child population and Oceania, Europe, Asia, and North America in the adult population. The annual trend of the average BPA intake was similar between the adult and child populations. The BPA intake in the two populations evidently decreased from 2000 to 2008 and then slightly increased from 2008 to 2011. The BPA intake in the child population started to decrease again from 2011, whereas the corresponding intake in the adult population continued to increase. The distinct difference likely contributed to the wide prohibition of the use of BPA in food-related products for children in many countries since 2009; the bans effectively decreased the total BPA exposure in the child population.

Worldwide human daily intakes of bisphenol A (BPA) estimated from global urinary concentration data (2000-2016) and its risk analysis.

To evaluate BPA's potential risk to health, it is important to know human daily intake. This study describes a simple but effective method to estimate the levels of human BPA intake among four different populations based on urinary concentration data. Nationally, of the 30 countries examined, the top ten countries for adult intake were Italy, Sweden, Denmark, France, Cyprus, Australia, Israel, Ghana, Jamaica, and Belgium. When the urinary excretion sample size was large enough and over 1000, it was found that the national estimated BPA daily intakes in the child group among countries, showed a good linear relationship with those of their corresponding adult group. Except the infant group with limited data, the global estimated BPA daily intakes for children and pregnant women were 2 and 1.4 times that of the adult group. Although the national and global estimated BPA daily intakes were generally below the temporary tolerable daily intake (tTDI) recommended by the European Food Safety Authority (EFSA), but some normal individuals' daily intakes exceeded the tTDI.

Levels of six antibiotics used in China estimated by means of wastewater-based epidemiology.

Due to lack of proper regulation, information about antibiotics consumption in many countries such as China is difficult to obtain. In this study, a simple method based on wastewater-based epidemiology was adopted to estimate their usage in four megacities of China. Six antibiotics (norfloxacin, ofloxacin, sulfamethoxazole, trimethoprim, erythromycin and roxithromycin), which are the most frequently consumed antibiotics in China, were selected as the targets. Based on our results, Chongqing had the largest total annual consumption of the selected six antibiotics among the four megacities, followed by Guangzhou, then Hong Kong, with Beijing having the least, with values of 4.4 g/y/P, 4.0 g/y/P, 1.6 g/y/P, and 1.3 g/y/P, respectively. Compared with the daily consumption per capita in Italy, the estimated consumption levels of the selected six antibiotics in four cities of China were 12-41 times those of Italy. Our results suggested that the consumption of antibiotics in China was excessive.